Neil Garry Arthur is CEO and Chairman of the Board of Avalo Therapeutics Inc.
Person profile
Roles
Avalo Therapeutics
CEO and Chairman of the Board
Celldex Therapeutics
Director
Zura Bio Ltd - Ordinary Shares
Director
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Celldex Therapeutics, Inc.
20 Jun 23
4
Avalo Therapeutics, Inc.
13 Jun 23
4
Zura Bio Ltd
22 May 23
4
Avalo Therapeutics, Inc.
17 May 23
3
Zura Bio Ltd
21 Mar 23
4
Avalo Therapeutics, Inc.
15 Feb 23
4
Avalo Therapeutics, Inc.
12 Dec 22
4
Avalo Therapeutics, Inc.
7 Oct 22
4
Celldex Therapeutics, Inc.
17 Jun 22
3
Celldex Therapeutics, Inc.
17 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 23 | CLDX Celldex Therapeutics | NQSO Common Stock | Grant | Acquire A | No | No | 36.87 | 11,300 | 416.63 k | 11,300 |
9 Jun 23 | AVTX Avalo Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.42 | 4,000 | 13.68 k | 13,220 |
18 May 23 | ZURA Zura Bio Ltd - Ordinary Shares | Employee Share Option Class A Ordinary Shares | Grant | Acquire A | No | No | 5.31 | 7,652 | 40.63 k | 7,652 |
15 May 23 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.75 | 100,000 | 275.00 k | 100,000 |